Product Information
MERCAPTOPURINE 50 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $1.0714 per EA under NDC 00054458111. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Feb 13, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054458111
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MERCAPTOPURINEApproval Type
Generic (ANDA)
FDA Application
ANDA040528FDA Approved
2/13/2004
TE Code
AB
On Market Since
2/13/2004
Pharmacological Classes
Price Statistics
The NADAC for MERCAPTOPURINE 50 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 15.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0714 per EA |
|---|---|
| All-time high | $2.4382 (Jul 15, 2015) |
| All-time low | $0.7913 (Nov 22, 2023) |
| 52-week high | $1.1574 |
| 52-week low | $0.9204 |
| Median price | $1.0971 |
| Average price | $1.2113 |
| Largest weekly change | +102.1% (Apr 17, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mercaptopurine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nucleoside Metabolic Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MERCAPTOPURINE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MERCAPTOPURINE 50 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $1.0714 per EA (NDC 00054458111), effective Sep 30, 2026.
How has the price of MERCAPTOPURINE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for MERCAPTOPURINE 50 MG TABLET has risen 15.8%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MERCAPTOPURINE 50 MG TABLET?
Since Nov 28, 2013, the NADAC for MERCAPTOPURINE 50 MG TABLET has ranged from a low of $0.7913 (Nov 22, 2023) to a high of $2.4382 (Jul 15, 2015), with a median of $1.0971 per EA.
Are there cheaper alternatives to MERCAPTOPURINE 50 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MERCAPTOPURINE 50 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MERCAPTOPURINE 50 MG TABLET?
MERCAPTOPURINE 50 MG TABLET (NDC 00054458111) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.